Cellectar Biosciences Reports First Quarter 2015 Financial Results and Provides Update on Clinical Programs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Cellectar Biosciences, Inc. (NASDAQ: CLRB) | Delayed: 1.22 +0.01 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $6.03 | |||
| Open | $1.23 | 52 Week Low | $0.41 | |||
| Day High | $1.26 | P/E | N/A | |||
| Day Low | $1.18 | EPS | $0.00 | |||
| Volume | 66,545 | |||||
| (NASDAQ: CLRBW) | Delayed: 0.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $1.40 | |||
| Open | $0.88 | 52 Week Low | $0.11 | |||
| Day High | $0.13 | P/E | N/A | |||
| Day Low | $0.13 | EPS | $0.00 | |||
| Volume | 214,095 | |||||
